klinische pädiatrie
130330
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Klinische Pädiatrie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
More About This Journal
Editorial Board
Table of Contents
German National License
Imprint
Media
Authors
Instructions for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
PharmaMarket
PharmaMarket
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Year (Archive)
2025
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
Issues
Current Issue
Free Sample Issue (01/2025)
Related Books
Pädiatrie
Abstracts der XVII. Jahrestagung der Kind-Philipp-Stiftung für Leukämieforschung
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
J
K
L
M
N
P
Q
R
S
T
V
W
Y
Z
Bader, P.
Haematopoietic chimerism and donor lymphocyte infusion after allogeneic SCT in children with non-malignant disease: is there an option to improve outcome?
Combined use of 4-color flow cytometry and real-time PCR to detect minimal residual disease (MRD) in childhood acute lymphoblastic leukemia
Banning, U.
Characterisation of apoptosis inductor and suppressor genes in thermochemotherapy treated Ewing tumor cells
[18F]fluorodeoxyglucose (FDG) in vitro uptake in Hodgkin Lymphoma
Role of IL-4 in collagen synthesis of allogeneic stimulated fibroblasts
Barthel, H.
[18F]fluorodeoxyglucose (FDG) in vitro uptake in Hodgkin Lymphoma
Bartl, S.
SV40 in childhood lymphoma – pathogen or passenger?
Beck, J. D.
Genomic structure and nucleotide sequence of AML1-ETO fusion genes in children with acute myeloid leukemia
Beck, J. F.
Haematopoietic chimerism and donor lymphocyte infusion after allogeneic SCT in children with non-malignant disease: is there an option to improve outcome?
Down-regulation of PKCη or Bcl-xL, but not Bcl-2, potentiates the cytotoxic effects of TRAIL in prostate cancer cells
Histone deacetylase Inhibitors have a profound proapoptotic activity in PNET cells
Beck, O.
Specific T-cell responses to aspergillus fumigatus antigens
Becker, J.
Keratoepithelin in neuroblastoma: molecular mechanisms and functional studies
Berthold, F.
Aberrantly regulated genes in TEL/AML1 positive leukaemia
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling
Berwanger, B.
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling
Bienemann, K.
Lentivirus-mediated osteosarcoma-selective chemogene therapy employing the human folylpolyglutamate synthetase/methotrexate system and the human osteocalcin promoter
Blazar, B. R.
L-selectin expression defines a subpopulation of In vitro generated AML-reactive T-cells with superior anti-leukemic efficacy for adoptive immunotherapy
Blümchen, K.
Prenatal manifestation of pancytopenia in Pearson Marrow-Pancreas Syndrome
Bochennek, K.
Comparison of five colour- flowcytometry and PCR in the detection of minimal residual disease in neuroblastoma
Boos, J.
Preclinical investigation of combination from the telomerase–inhibitor BRACO 20 with cisplatin and the effects of sole BRACO 20 treatment on neuroblastoma cells
Doxorubicin reduces telomerase activity in a human Ewing-Xenograft tumor
Brachwitz, K.
Clear cell sarcoma of soft parts (CCSST): functional analysis of ERBB3
Braun, Y.
Clear cell sarcoma of soft parts (CCSST): functional analysis of ERBB3
Effects of telomerase switch in neuroblastoma cell lines
Doxorubicin reduces telomerase activity in a human Ewing-Xenograft tumor
Brinkmann, A.
Comparison of five colour- flowcytometry and PCR in the detection of minimal residual disease in neuroblastoma
Brors, B.
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling
Brune, H.
The M6P/IGF2-receptor gene shows allelic loss but is not mutated in ependymomas
SOX18 is a target gene of the Shh-Ptc pathway in murine cerebellar granule cell precursors and is highly expressed in human desmoplastic medulloblastomas
Bursen, A.
The human proto-oncoprotein AF4 interacts with the E3-ligases SIAH1 and SIAH2
Busche, B.
Differentiation of myeloid leukemia cells by HDAC-inhibitors
Buslei, R.
SOX18 is a target gene of the Shh-Ptc pathway in murine cerebellar granule cell precursors and is highly expressed in human desmoplastic medulloblastomas